GlassScriptPhysician profile
Basman Abdel Salous
NPI 1982687521
$10,354.74
in general payments reported to CMS, 2019-2025
49 companies · $1,167 in 2025
The $1,167 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,492 · 2020: $1,078 · 2021: $1,485 · 2022: $2,017 · 2023: $1,421 · 2024: $1,694 · 2025: $1,167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,282.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,488.26 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $1,127.24 | 2019-2025 | Vraylar |
| Astrazeneca Pharmaceuticals LP | $884.82 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $637.08 | 2019-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $623.82 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $471.35 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $451.73 | 2020-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $425.43 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $404.97 | 2019-2025 | Gardasil 9, Vaxelis, Gardasil |
| Takeda Pharmaceuticals U.S.A., INC. | $323.73 | 2019-2023 | Trintellix |
| Genentech USA, INC. | $296.80 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $279.42 | 2021-2024 | |
| Abbott Laboratories | $262.64 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $245.91 | 2019-2023 | Evenity, Prolia |
| Astellas Pharma US INC | $236.90 | 2019-2024 | Veozah, Myrbetriq |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basman Salous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.